Abstract
The arm of this review was to help general pediatricians and primary care physicians in diagnosing and managing cow’s milk protein allergy in exclusively breast-fed infants.
Allergic proctocolitis is a cause of rectal bleeding in exclusively breast-fed infants aged from 1 to 6 months.It is due to cow’s milk protein transferred via breast milk. Diagnosis is based on clinical features and recovery after dietetic therapy. Rectal bleeding generally resolves within 72-96 hours of cow’s milk protein maternal avoidance. Most infants tolerate cow’s milk by their first birthday.
Keywords: Allergic proctocolitis, α-S1-casein, β-lactoglobulin, blood streaked stool, breast-fed infants, cow’s milk proteins, non-IgE mediated immunologic reactions.
Endocrine, Metabolic & Immune Disorders - Drug Targets
Title:Refractory Proctocolitis in the Exclusively Breast-Fed Infants
Volume: 14 Issue: 1
Author(s): Marina Atanaskovic-Markovic
Affiliation:
Keywords: Allergic proctocolitis, α-S1-casein, β-lactoglobulin, blood streaked stool, breast-fed infants, cow’s milk proteins, non-IgE mediated immunologic reactions.
Abstract: The arm of this review was to help general pediatricians and primary care physicians in diagnosing and managing cow’s milk protein allergy in exclusively breast-fed infants.
Allergic proctocolitis is a cause of rectal bleeding in exclusively breast-fed infants aged from 1 to 6 months.It is due to cow’s milk protein transferred via breast milk. Diagnosis is based on clinical features and recovery after dietetic therapy. Rectal bleeding generally resolves within 72-96 hours of cow’s milk protein maternal avoidance. Most infants tolerate cow’s milk by their first birthday.
Export Options
About this article
Cite this article as:
Atanaskovic-Markovic Marina, Refractory Proctocolitis in the Exclusively Breast-Fed Infants, Endocrine, Metabolic & Immune Disorders - Drug Targets 2014; 14 (1) . https://dx.doi.org/10.2174/1871530314666140121145800
DOI https://dx.doi.org/10.2174/1871530314666140121145800 |
Print ISSN 1871-5303 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3873 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Molecular Classification and Drug Response Prediction in Cancer
Current Drug Targets Gene-Gene and Gene-Clinical Factors Interaction in Acute Myocardial Infarction: A New Detailed Risk Chart
Current Pharmaceutical Design Endoplasmic Reticulum Dysfunction in Brain Pathology: Critical Role of Protein Synthesis
Current Neurovascular Research Microdialysis Approach to Study Serotonin Outflow in Mice Following Selective Serotonin Reuptake Inhibitors and Substance P (Neurokinin 1) Receptor Antagonist Administration: A Review
Current Drug Targets Serum Bilirubin after Acute Ischemic Stroke is Associated with Stroke Severity
Current Neurovascular Research Harnessing Impaired Energy Metabolism in Cancer Cell: Small Molecule- Mediated Ways to Regulate Tumorigenesis
Anti-Cancer Agents in Medicinal Chemistry Effects of Apelin Peptides on Diabetic Complications
Current Protein & Peptide Science Dipeptidyl Peptidase IV Inhibitors: A New Paradigm in Type 2 Diabetes Treatment
Current Drug Targets Metabolic Syndrome, Mild Cognitive Impairment and Dementia
Current Alzheimer Research Metabolic Effects of Bile Acids in the Gut in Health and Disease
Current Medicinal Chemistry Prenatal Stress Enhances Susceptibility to Allergic Diseases of Offspring
Endocrine, Metabolic & Immune Disorders - Drug Targets Therapeutic Strategies for Treatment of Inflammation-related Depression
Current Neuropharmacology Beta-Blockers in the Treatment of Dilated Cardiomyopathy: Which is the Best?
Current Pharmaceutical Design Therapeutic Strategies in Pulmonary Hypertension of the Newborn: Where Are We Now?
Current Medicinal Chemistry Evidence for Epigenetic Alterations in Turner Syndrome Opens up Feasibility of New Pharmaceutical Interventions
Current Pharmaceutical Design Approaches to the Management of Acute Kidney Injury in Children
Recent Patents on Biomarkers Somatostatin Receptor-Targeted Anti-Cancer Therapy
Current Drug Delivery Antipsychotics in the Treatment of Impulsivity in Personality Disorders and Impulse Control Disorders
Current Psychopharmacology Vitamin D Supplementation for Obesity: Potential Mechanisms of Action and an Update of Randomized Controlled Trials
Current Nutrition & Food Science The Role of Inflammation and Allergy in Acute Coronary Syndromes
Inflammation & Allergy - Drug Targets (Discontinued)